Insulin Detemir Latest News

Comparing long-acting insulins? Tresiba may come out ahead. With the exception of NPH insulins like Humulin N and Novolin N (which are now considered to be intermediate acting), they are all going to cost you. So, if you are already paying big bucks for your long-acting insulin, here are some things to think about.

What is a long-acting or basal insulin?

This is your baseline insulin, the insulin that is secreted to control your sugars when you are not eating (also known as the fasting state). See More

Despite outrage over the high cost of insulin, prices for popular insulin treatments have continued to climb in 2018, according to a GoodRx analysis of drug prices.

Though prices are not climbing as quickly as they did between 2002 and 2013—when the average cost of insulin therapy tripled—the average price of insulin has increased by 64% since January 2014. Since the beginning of 2017, when drug prices became a key part of White House agenda, insulin prices have increased by 9% on average. See More

Cutting down or rationing insulin has dire consequences for all type 1 as well as type 2 diabetics dependent on insulin. Working in a busy practice alongside an endocrinologist with predominantly type 1 diabetic patients, I’ve seen the team behind our doctors working hard to keep insulin affordable for patients. Here is what I’ve learned from the best.

Steps for insured patients

If you’re about to take insulin, choose one that’s preferred:

1. Call your insurance first to find their preferred insulin products.
 See More

Long-acting insulins are only administered once or twice daily, and include drugs like Lantus, Toujeo, Basaglar, and Levemir. As of March 27th, we have a new one to add to the long-acting insulin family – Toujeo Max SoloStar.

What is Toujeo Max SoloStar indicated for?

Toujeo Max SoloStar is indicated to improve blood sugar control in adults with diabetes. It will be available in a 3 ml disposable prefilled SoloStar pen in the strength of 300 units/ml. See More

One of the only ways to treat diabetes type 1 and 2 are through insulin injections, like Lantus (insulin glargine), that help to control blood sugar. Unfortunately, doctors consistently report low levels of adherence to insulins, Lantus included. The main reason? The cost.

Lantus is a prime example of an expensive insulin—averaging around $274 per month, it is unaffordable for many. But GoodRx is here to help.

Here is some information on Lantus, and how you can save

Why are insulins, and Lantus, so expensive?

The case of insulin prices is an interesting one. See More

For people who need to take insulin, there are a couple of different types—long-acting, short-acting, rapid-acting, intermediate-acting, etc. That’s a lot of options!

One question I see most often is the difference between rapid-acting and long-acting insulins. So, let’s get into it.   

What is rapid-acting insulin?

Rapid-acting, or meal-time insulin, is a type of insulin that’s usually taken before, during, or after a meal to lower your blood sugar levels associated with meals. See More

You can now find and compare diabetes supplies on GoodRx! Do a search now to see prices for glucose test strips and meters, control solution, syringes and lancets, and more.

As you may already know, shopping around online will typically get you a lower price than what you’ll find walking in to your local pharmacy.

To make it even easier to get the most savings, you can now order discounted supplies directly from Total Diabetes Supply—in addition to the low Amazon. See More

There have been several new insulin products approved over the past year, including Toujeo, Humalog U-200, Afrezza—and now Tresiba and Ryzodeg.

The other recent insulin approvals are what I like to call spin-off insulin products. For example, Toujeo has the same type of insulin as Lantus (insulin glargine), but is more concentrated. Humalog U-200 is the same exact product as Humalog U-100 (insulin lispro), but once again, more concentrated. See More

More than 29 million Americans have diabetes. That’s more than 10% of the US—and that number continues to rise. More than 1.7 million adults were diagnosed with diabetes in 2012 alone.

Fortunately, several new medications for diabetes have recently been approved—Toujeo (a new insulin product), Synjardy (a new combination of empagliflozin/metformin) and others. These new drugs provide several benefits such as fewer side effects or foolproof self-dosing with an insulin pen. See More

Did you read our blog on insulin vials and think to yourself, does this apply to my insulin pens too? If so, this post is for you!

With so many different insulin and insulin-like products out there these days it can be hard keep track of how long each of these pens stays good.

Depending on your dose, you may still have insulin left in your pen at the manufacturer-recommended time to throw it away. If this sounds like a familiar situation, know that it is important to throw away your pen regardless of whether you have any leftover. See More